Sci Rep: The researchers found predictive factors for the success of laser therapy in glacial eye patients.

7, 2020 /--- - More than 70 million people worldwide suffer from glare, a disease that causes water and stress to build up in the eyes and eventually lead to blindness.
traditional treatments include eye drops to reduce fluid produced by the eyes, or surgery to clear the eyes.
, a new study from the University of Missouri School of Medicine and MU Health Care could reveal which patients might benefit from non-invasive treatments for selective laser beam forming (SLT).
, author of the paper, said: "Previously we lacked evidence of SLT safety and ideal drug candidates.
little is known about SLT, experts have doubts about its use as a first-line treatment for glare.
our findings help redefine the ideal patient for the procedure.
(Photo source: www.pixabay.com) An's team analyzed data from 198 adult open-angle glaswing patients who underwent 252 SLT operations, revealing how many of them had a reduction in eye pressure (IOP) by more than 20 percent.
months after the operation, 33.6 percent of patients met the success criteria.
38.5 per cent in the next six months.
researchers found that patients with higher baseline IOP were more stressed.
"we found a marked improvement in the condition of patients with severe illness, which convinced me that the most stressed patients would benefit most from this laser treatment.
" age, type and severity of glare did not significantly predict the prognostication of success.
, less than 5% of patients experienced the most common adverse events of the IOP peak after surgery.
study provides evidence that SLT is the primary therapy.
", the study's lead author was Dr. Matthew Hirabayashi, an ophthalmologist at MU Medical School.
Vikram Ponnusamy of the Mu School of Medicine in New York contributed to this finding.
(bioon.com) Source: Researchers discovery predictor of laser treatment in patients with glaucoma Source: Matthew Hirabayashi, Vikram Ponnusamy, Jella An. Predictive Factors for Selectives of Laser Trabeculoplasty. Scientific Reports, 2020; 10 (1) DOI: 10.1038/s41598-020-66473-0.